Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations
- Author
- CONIL, Jean-Marie1 ; GEORGES, Bernard1 ; RAVAT, François2 ; RUIZ, Stéphanie1 ; SEGUIN, Thierry1 ; METSU, David3 ; FOURCADE, Olivier1 ; SAIVIN, Sylvie3
[1] Anesthésie Reanimation, CHU Rangueil, Toulouse, France
[2] Centre des brûlés, Centre hospitalier, Lyon, France
[3] Laboratoire de Pharmacocinétique et Toxicologie Clinique, Institut Fédératif de Biologie, Toulouse, France - Source
Clinical therapeutics. 2013, Vol 35, Num 10, pp 1603-1612, 10 p ; ref : 30 ref
- ISSN
- 0149-2918
- Scientific domain
- Pharmacology drugs
- Publisher
- Elsevier, Bridgewater, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Monte Carlo simulations burn ceftazidime dosage regimen pharmacokinetics
- Keyword (fr)
- Antibactérien Antibiotique Brûlure Ceftazidime Homme Pharmacocinétique de la population Posologie Recommandation Simulation Dérivé de la céphalosporine β-Lactamines
- Keyword (en)
- Antibacterial agent Antibiotic Burn Ceftazidime Human Population pharmacokinetics Posology Recommendation Simulation Cephalosporin derivatives β-Lactams
- Keyword (es)
- Antibacteriano Antibiótico Quemadura Ceftazidima Hombre Farmacocinética población Posología Recomendación Simulación Cefalosporina derivado β-Lactams
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B16 Traumas. Diseases due to physical agents / 002B16J Burns
- Discipline
- General pharmacology Traumas. Diseases caused by physical agents
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27860218
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.clinthera.2013.08.014 
https://dx.doi.org/10.1016/j.clinthera.2013.08.014
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2013.08.014\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1603\";s:8:\"\u0000*\u0000epage\";s:4:\"1612\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CONIL\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Jean-Marie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"GEORGES, Bernard\";i:1;s:16:\"RAVAT, Fran\u00e7ois\";i:2;s:16:\"RUIZ, St\u00e9phanie\";i:3;s:15:\"SEGUIN, Thierry\";i:4;s:12:\"METSU, David\";i:5;s:17:\"FOURCADE, Olivier\";i:6;s:14:\"SAIVIN, Sylvie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2013.08.014\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1603\";s:8:\"\u0000*\u0000epage\";s:4:\"1612\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CONIL\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Jean-Marie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"GEORGES, Bernard\";i:1;s:16:\"RAVAT, Fran\u00e7ois\";i:2;s:16:\"RUIZ, St\u00e9phanie\";i:3;s:15:\"SEGUIN, Thierry\";i:4;s:12:\"METSU, David\";i:5;s:17:\"FOURCADE, Olivier\";i:6;s:14:\"SAIVIN, Sylvie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2013.08.014\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2013.08.014\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1603\";s:8:\"\u0000*\u0000epage\";s:4:\"1612\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CONIL\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Jean-Marie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"GEORGES, Bernard\";i:1;s:16:\"RAVAT, Fran\u00e7ois\";i:2;s:16:\"RUIZ, St\u00e9phanie\";i:3;s:15:\"SEGUIN, Thierry\";i:4;s:12:\"METSU, David\";i:5;s:17:\"FOURCADE, Olivier\";i:6;s:14:\"SAIVIN, Sylvie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2013.08.014\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1603\";s:8:\"\u0000*\u0000epage\";s:4:\"1612\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CONIL\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Jean-Marie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"GEORGES, Bernard\";i:1;s:16:\"RAVAT, Fran\u00e7ois\";i:2;s:16:\"RUIZ, St\u00e9phanie\";i:3;s:15:\"SEGUIN, Thierry\";i:4;s:12:\"METSU, David\";i:5;s:17:\"FOURCADE, Olivier\";i:6;s:14:\"SAIVIN, Sylvie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2013.08.014\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1603\";s:8:\"\u0000*\u0000epage\";s:4:\"1612\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CONIL\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Jean-Marie\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"GEORGES, Bernard\";i:1;s:16:\"RAVAT, Fran\u00e7ois\";i:2;s:16:\"RUIZ, St\u00e9phanie\";i:3;s:15:\"SEGUIN, Thierry\";i:4;s:12:\"METSU, David\";i:5;s:17:\"FOURCADE, Olivier\";i:6;s:14:\"SAIVIN, Sylvie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:144:\"Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
